Concepedia

David A. Jolliffe

DA

Statistics

Publications

43

Citations

2.3K

H-Index

26

Active since

1986

Affiliations

Queen Mary University of London(Current)

Asthma UK

University of Edinburgh

Swansea University

Queen's University Belfast

David A. Jolliffe is an author at Queen Mary University of London specializing in vitamin d, medicine, and infectious diseases.

ORCID

Publications per year

1986–2024

43

Publications

43

Extent of overweight among US children and adolescents from 1971 to 2000

David A. Jolliffe · International Journal of Obesity · 2003 · 246 citations

, , +9

Vitamin D 3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial

Adrian R. Martineau, Wai Yee James, Richard Hooper et al. · The Lancet Respiratory Medicine · 2014 · 232 citations

, , +12

A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet<sup>®</sup>/Daivobet<sup>®</sup>/Taclonex<sup>®</sup>) in the treatment of psoriasis vulgaris

Knud Kragballe, Joar Austad, Larry D. Barnes et al. · British Journal of Dermatology · 2006 · 138 citations

, , +9

Double-blind randomised placebo-controlled trial of bolus-dose vitamin D<sub>3</sub>supplementation in adults with asthma (ViDiAs)

Adrian R. Martineau, Beverley MacLaughlin, Richard Hooper et al. · Thorax · 2015 · 122 citations · Full text

, , +16

Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT)

David A. Jolliffe, Hayley Holt, Matthew Greenig et al. · BMJ · 2022 · 112 citations · Full text

, , +17

1–5 of 43